Hello MLA & SLA: we can't wait to meet you in May!
STAT+ provides access to exclusive journalism written by the nation's most trusted reporters in hospitals and insurance, biotech, pharma, policy, and the life sciences. In addition to unlimited story access, subscribers also benefit from:
- free admission to more than a dozen virtual & hybrid events with our teams, thought leaders, and industry experts,
- premium tracking tools on CRISPR, drug pricing policies, and the FDA’s fast-tracked medical devices,
- breaking news alerts & subscriber-only newsletters,
- and discounted access to our summits, to the STAT Reports Library, and to our clinical trials intelligence platform, STAT Trials Pulse.
Learn more at https://www.statnews.com/stat-plus/.
Click here to book some time for a quick meeting while we're together in Detroit.